GLP1R and Insulin resistance: Conversely, preventing or reversing microvascular insulin resistance using a variety of approaches, including muscle contraction30, adiponectin19, GLP-1 or GLP-1 receptor agonist31,32, angiotensin II receptor antagonist33, and inhibition of vascular inflammation16, all enhanced metabolic insulin responses in insulin resistant rodents.